NASDAQ : BGLC
BioNexus Gene Lab Corp. — Financial statements
Materials · Specialty Chemicals · Malaysia
Last price 0.98 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.87M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
BioNexus Gene Lab Corp. (BGLC) reported revenue of 3.13M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 3.13M | 7.42M | 9.51M | 9.77M | 10.93M | 13.36M |
| Cost of Revenue | 2.74M | 6.34M | 8.22M | 8.44M | 9.67M | 11.10M |
| Gross Profit | 385.89K | 1.09M | 1.29M | 1.33M | 1.26M | 2.27M |
| Selling, General & Admin | 1.93M | 3.27M | 3.86M | 3.04M | 1.73M | 1.28M |
| Research & Development | 54.13K | 50.67K | 47.51K | 54.98K | ||
| Other Operating Expenses | 30.79K | -59.48K | -59.41K | -42.09K | -249.91K | -66.49K |
| Operating Expenses | 3.14M | 4.18M | 3.19M | 4.37M | 1.48M | 1.21M |
| Operating Income | -2.76M | -3.10M | -1.90M | -3.04M | -220.55K | 1.06M |
| Interest Expense | -16.89K | -19.54K | -21.15K | -13.93K | -12.48K | -12.97K |
| Interest & Investment Income | 73.47K | 106.00K | 215.77K | 130.08K | ||
| Currency Exchange Gain (Loss) | -89.00K | -94.66K | ||||
| Other Non Operating Income (Expenses) | 1.40K | 1.40K | ||||
| EBT Excluding Unusual Items | -2.79M | -3.11M | -1.70M | -2.92M | -233.03K | 1.04M |
| Gain (Loss) on Sale of Investments | 212.41K | 121.17K | 107.89K | 313.86K | -70.63K | |
| Pretax Income | -2.58M | -2.98M | -1.59M | -2.61M | -303.66K | 1.04M |
| Income Tax Expense | 3.49K | 21.53K | 52.31K | 291.28K | ||
| Net Income | -2.58M | -2.98M | -1.60M | -2.63M | -355.97K | 751.57K |
| Net Income to Common | -2.58M | -2.98M | -1.60M | -2.63M | -355.97K | 751.57K |
| Shares Outstanding (Basic) | 2.17M | 1.86M | 1.78M | 1.59M | 1.44M | 1.43M |
| Shares Outstanding (Diluted) | 2.17M | 1.86M | 1.78M | 1.59M | 1.44M | 1.43M |
| EPS (Basic) | -1.19 | -1.61 | -0.90 | -1.66 | -0.25 | 0.53 |
| EPS (Diluted) | -1.19 | -1.61 | -0.90 | -1.66 | -0.25 | 0.53 |
| Free Cash Flow | -853.60K | -1.88M | -2.32M | -1.97M | 497.65K | 6.00K |
| Free Cash Flow Per Share | -0.39 | -1.01 | -1.30 | -1.24 | 0.34 | 0.00 |
| Gross Margin | 12.34% | 14.62% | 13.56% | 13.61% | 11.52% | 16.96% |
| Operating Margin | -88.16% | -41.74% | -19.95% | -31.09% | -2.02% | 7.90% |
| Profit Margin | -82.36% | -40.20% | -16.81% | -26.91% | -3.26% | 5.62% |
| Free Cash Flow Margin | -27.30% | -25.26% | -24.40% | -20.18% | 4.55% | 0.04% |
| EBITDA | -2.64M | -2.99M | -1.79M | -2.95M | -129.12K | 1.15M |
| EBITDA Margin | -84.44% | -40.23% | -18.86% | -30.24% | -1.18% | 8.58% |
| D&A For EBITDA | 116.51K | 111.87K | 104.16K | 83.25K | 91.43K | 91.28K |
| EBIT | -2.76M | -3.10M | -1.90M | -3.04M | -220.55K | 1.06M |
| EBIT Margin | -88.16% | -41.74% | -19.95% | -31.09% | -2.02% | 7.90% |
| Effective Tax Rate | 27.93% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.23M | 2.38M | 1.58M | 2.62M | 611.85K | 578.51K |
| Short-Term Investments | 2.29M | 1.66M | 2.79M | 3.31M | 1.51M | 1.55M |
| Cash & Short-Term Investments | 3.52M | 4.04M | 4.38M | 5.93M | 2.12M | 2.12M |
| Accounts Receivable | 15.54K | 505.88K | 1.38M | 799.67K | 2.87M | 3.36M |
| Other Receivables | 170.11K | 143.11K | 287.83K | 180.02K | 56.79K | 79.52K |
| Receivables | 185.65K | 649.00K | 1.66M | 979.69K | 2.93M | 3.44M |
| Inventory | 652.89K | 676.70K | 1.39M | 1.14M | 977.81K | 1.52M |
| Other Current Assets | 583.33K | 83.33K | 67.61K | |||
| Total Current Assets | 4.94M | 5.45M | 7.43M | 8.05M | 6.02M | 7.15M |
| Property, Plant & Equipment | 1.76M | 1.78M | 1.74M | 1.65M | 1.57M | 1.68M |
| Long-Term Investments | 2.03M | 2.03M | 1.27M | 1.70M | 1.15M | 749.03K |
| Total Assets | 8.73M | 9.25M | 10.43M | 11.40M | 8.74M | 9.57M |
| Accounts Payable | 7.90K | 2.33K | 1.50M | 1.40M | 1.86M | 2.01M |
| Short-Term Debt | 124.61K | 49.48K | 17.17K | 13.20K | ||
| Current Portion of Leases | 63.54K | 59.15K | 50.82K | 34.63K | 16.57K | 39.51K |
| Current Income Taxes Payable | 97.58K | |||||
| Current Unearned Revenue | 77.28K | |||||
| Other Current Liabilities | 616.89K | 410.00K | 379.99K | 180.91K | 126.49K | 102.12K |
| Total Current Liabilities | 812.94K | 520.96K | 1.95M | 1.63M | 2.00M | 2.33M |
| Long-Term Leases | 135.04K | 116.90K | 159.74K | 98.76K | 40.21K | 37.44K |
| Long-Term Deferred Tax Liabilities | 12.26K | 30.87K | 28.42K | |||
| Total Liabilities | 947.98K | 637.86K | 2.11M | 1.74M | 2.08M | 2.39M |
| Common Stock | 20.17M | 20.17M | 17.33M | 17.19M | 10.93M | 10.78M |
| Retained Earnings | -7.26M | -6.43M | -3.44M | -1.84M | 1.16M | 1.51M |
| Comprehensive Income & Other | -5.14M | -5.13M | -5.57M | -5.69M | -5.42M | -5.11M |
| Shareholders' Equity | 7.78M | 8.61M | 8.32M | 9.66M | 6.67M | 7.18M |
| Total Liabilities & Equity | 8.73M | 9.25M | 10.43M | 11.40M | 8.74M | 9.57M |
| Total Debt | 323.20K | 225.53K | 227.73K | 146.59K | 56.77K | 76.95K |
| Net Cash (Debt) | 3.20M | 3.81M | 4.15M | 5.78M | 2.06M | 2.05M |
| Net Cash Per Share | 1.48 | 2.05 | 2.33 | 3.64 | 1.43 | 1.43 |
| Filing Date Shares Outstanding | 2.93M | 2.42M | 1.80M | 1.77M | 1.45M | 1.43M |
| Total Common Shares Outstanding | 2.42M | 2.42M | 1.80M | 1.77M | 1.45M | 1.43M |
| Working Capital | 4.13M | 4.93M | 5.48M | 6.42M | 4.02M | 4.82M |
| Book Value Per Share | 3.22 | 3.56 | 4.63 | 5.47 | 4.60 | 5.03 |
| Tangible Book Value | 7.78M | 8.61M | 8.32M | 9.66M | 6.67M | 7.18M |
| Tangible Book Value Per Share | 3.22 | 3.56 | 4.63 | 5.47 | 4.60 | 5.03 |
| Land | 1.51M | 1.51M | 1.51M | 1.51M | 1.51M | 1.51M |
| Machinery | 907.46K | 906.88K | 880.30K | 680.74K | 647.52K | 593.35K |
| Construction In Progress | 109.51K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -2.58M | -2.98M | -1.60M | -2.63M | -355.97K | 751.57K |
| Depreciation & Amortization | 176.83K | 168.31K | 153.14K | 108.42K | 105.42K | 108.22K |
| Asset Writedown & Restructuring Costs | 40.17K | 18.00 | ||||
| Loss (Gain) From Sale of Investments | -24.48K | 66.76K | -107.89K | -307.67K | 72.40K | 29.85K |
| Stock-Based Compensation | 794.77K | 794.77K | 141.00K | |||
| Provision & Write-off of Bad Debts | 333.77K | 126.44K | -799.53K | 949.06K | 4.17K | 3.81K |
| Other Operating Activities | -4.55K | -22.11K | -37.21K | -60.98K | -107.58K | -22.04K |
| Change in Accounts Receivable | 1.46M | 782.84K | 147.76K | 650.81K | 538.65K | 579.22K |
| Change in Inventory | 562.73K | 711.92K | -250.85K | -160.39K | 544.11K | -345.75K |
| Change in Accounts Payable | -1.06M | -1.38M | 204.34K | -381.29K | -119.69K | -1.18M |
| Change in Unearned Revenue | -77.28K | 77.28K | ||||
| Change in Income Taxes | 40.34K | 22.78K | -38.83K | -44.65K | 13.87K | 65.01K |
| Change in Other Net Operating Assets | -554.12K | -122.00K | 52.98K | 53.50K | -66.26K | -57.47K |
| Operating Cash Flow | -846.57K | -1.84M | -2.09M | -1.82M | 551.82K | 9.16K |
| Capital Expenditures | -7.04K | -36.97K | -226.99K | -149.40K | -54.17K | -3.16K |
| Investment in Securities | 1.02M | 1.02M | 576.04K | -294.59K | -511.71K | -509.45K |
| Other Investing Activities | 375.65K | -40.75K | 69.15K | -1.35M | 115.38K | 22.04K |
| Investing Cash Flow | 1.39M | 944.75K | 418.20K | -1.79M | -450.50K | -490.57K |
| Short-Term Debt Issued | 32.30K | 3.98K | 13.20K | |||
| Total Debt Issued | 107.44K | 32.30K | 3.98K | 13.20K | ||
| Short-Term Debt Repaid | -1.92K | |||||
| Long-Term Debt Repaid | -34.04K | -26.30K | ||||
| Total Debt Repaid | -432.00 | -34.04K | -28.22K | |||
| Net Debt Issued (Repaid) | 107.01K | 32.30K | 3.98K | 13.20K | -34.04K | -28.22K |
| Issuance of Common Stock | 267.31K | 267.31K | 6.26M | 150.00K | ||
| Other Financing Activities | -270.00 | -775.00 | -7.79K | |||
| Financing Cash Flow | 374.05K | 298.84K | 3.98K | 6.27M | 108.17K | -28.22K |
| Foreign Exchange Rate Adjustments | -63.81K | 194.21K | 40.34K | -259.68K | -214.55K | -154.14K |
| Net Cash Flow | 854.76K | -400.58K | -1.63M | 2.40M | -5.05K | -663.77K |
| Free Cash Flow | -853.60K | -1.88M | -2.32M | -1.97M | 497.65K | 6.00K |
| Free Cash Flow Margin | -27.30% | -25.26% | -24.40% | -20.18% | 4.55% | 0.04% |
| Free Cash Flow Per Share | -0.39 | -1.01 | -1.30 | -1.24 | 0.34 | 0.00 |
| Levered Free Cash Flow | 68.31K | -849.95K | -1.77M | -567.06K | 726.84K | -109.90K |
| Unlevered Free Cash Flow | 78.87K | -837.74K | -1.75M | -558.35K | 734.64K | -101.79K |
| Cash Interest Paid | 4.56K | 6.87K | 9.35K | 8.88K | 12.48K | 12.97K |
| Cash Income Tax Paid | -28.83K | 40.38K | 66.97K | 170.45K | 226.77K | |
| Change in Working Capital | 452.24K | 12.05K | 115.40K | 117.98K | 833.38K | -862.25K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.69M | 9.34M | 5.03M | 9.36M | 165.03M | 364.69M |
| Enterprise Value | -506.90K | 6.68M | 1.13M | 3.36M | 163.60M | 363.08M |
| Last Close Price | 0.92 | 3.95 | 2.80 | 5.30 | 114.00 | 255.60 |
| PE Ratio | 485.24 | |||||
| PS Ratio | 0.86 | 1.26 | 0.53 | 0.96 | 15.10 | 27.29 |
| PB Ratio | 0.29 | 1.08 | 0.60 | 0.97 | 24.76 | 50.80 |
| P/TBV Ratio | 0.35 | 1.08 | 0.60 | 0.97 | 24.76 | 50.80 |
| P/FCF Ratio | 331.62 | 60,792.56 | ||||
| P/OCF Ratio | 299.07 | 39,809.47 | ||||
| EV/Sales Ratio | 0.90 | 0.12 | 0.34 | 14.97 | 27.17 | |
| EV/EBITDA Ratio | 316.52 | |||||
| EV/EBIT Ratio | 343.88 | |||||
| EV/FCF Ratio | 328.74 | 60,523.49 | ||||
| Debt / Equity Ratio | 0.04 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 |
| Debt / EBITDA Ratio | 0.07 | |||||
| Debt / FCF Ratio | 0.11 | 12.83 | ||||
| Net Debt / Equity Ratio | -0.41 | -0.44 | -0.50 | -0.60 | -0.31 | -0.28 |
| Net Debt / EBITDA Ratio | 1.21 | 1.28 | 2.31 | 1.96 | 15.97 | -1.78 |
| Net Debt / FCF Ratio | 3.75 | 2.03 | 1.79 | 2.93 | -4.14 | -341.22 |
| Asset Turnover | 0.34 | 0.75 | 0.87 | 0.97 | 1.19 | 1.36 |
| Inventory Turnover | 2.93 | 6.14 | 6.51 | 7.98 | 7.74 | 8.22 |
| Quick Ratio | 4.56 | 9.00 | 3.10 | 4.24 | 2.52 | 2.39 |
| Current Ratio | 6.08 | 10.46 | 3.81 | 4.93 | 3.00 | 3.07 |
| Return on Equity (ROE) | -33.66% | -35.24% | -17.78% | -32.21% | -5.14% | 10.86% |
| Return on Assets (ROA) | -18.99% | -19.68% | -10.86% | -18.85% | -1.50% | 6.70% |
| Return on Invested Capital (ROIC) | -60.88% | -69.07% | -47.15% | -71.66% | -4.53% | 16.67% |
| Return on Capital Employed (ROCE) | -34.80% | -35.50% | -22.40% | -31.10% | -3.30% | 14.60% |
| Earnings Yield | -129.52% | -31.96% | -31.80% | -28.08% | -0.22% | 0.21% |
| FCF Yield | -31.72% | -20.09% | -46.17% | -21.05% | 0.30% | 0.00% |
| Buyback Yield / Dilution | -20.61% | -4.20% | -12.24% | -10.17% | -0.99% | -66.36% |